Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset Meeting Abstract
| Authors: | Garralda, E.; Hong, D.; Xu, R.; Deeken, J.; Italiano, A.; Liu, T.; Ferrandiz, A.; Patel, J.; Lee, D.; Chung, H.; Kinoshita, I.; Berlin, J.; André, T.; Oh, D.; Leyvraz, S.; Miguel, M.; Liu, Y.; Norenberg, R.; Fellous, M.; Mussi, C.; Drilon, A.; Shen, L. |
| Abstract Title: | Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset |
| Meeting Title: | ESMO 24th World Congress on Gastrointestinal Cancer 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2022 Jun 29-Jul 2 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-06-01 |
| Start Page: | S370 |
| Language: | English |
| ACCESSION: | WOS:000823826500350 |
| DOI: | 10.1016/j.annonc.2022.04.430 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: SO-31 -- Source: Wos |
